Form 4 Filing for Estrella Immunopharma, Inc.

This filing details stock transactions by Xu Jiandong, Chief Financial Officer of Estrella Immunopharma, Inc. On September 11, 2025, Mr. Xu acquired 100 shares of common stock at $1.04 per share, increasing his direct holdings to 264,588 shares. On September 22, 2025, 1000 shares were acquired indirectly through his spouse at $1.16 per share, resulting in 16,700 shares held indirectly. On October 7, 2025, Mr. Xu directly acquired an additional 1000 shares at $1.33 per share, bringing his total direct shares to 265,488. The filing indicates these transactions were purchases (Code P) and acquisitions (Code A).